A California-based medical device company that makes a femoral artery access device is seeking $19 million and has raised $16.5 million of that, according to a regulatory filing. Arstasis makes the ...

Durham, NC - The benefits of femoral arteriotomy-closure devices (ACDs) remain uncertain, and better randomized trials are needed to determine which patients are most likely to benefit from them, ...

Transluminal Technologies LLC, a Syracuse, New York-based medical device company, has received CE Mark approval for the velox CD Vascular Closure Device. Velox CD provides a safe and predictable means ...

For large-bore arterial access site closure after transfemoral transcatheter aortic valve replacement (TAVR), use of the Manta plug-based vascular closure device resulted in significantly more ...

Please provide your email address to receive an email when new articles are posted on . Jolly and colleagues designed the UNIVERSAL randomized trial to evaluate outcomes of ultrasound-guided with ...

For patients undergoing coronary procedures via transfemoral access, ultrasound guidance decreases the combined outcome of major vascular complications or bleeding and is particularly valuable when ...

Abbott Park, IL - The US Food and Drug Administration has approved the StarClose vascular closure system (Abbott), used for femoral-artery closure following diagnostic catheterization procedures, the ...